Drug delivery systems based on degradable cationic siloxanyl...

Details Drug delivery systems based on degradable cationic siloxanyl... Drug delivery systems based on degradable cationic siloxanyl...

2006-09-27

2009-08-25

Landau, Sharmila Gollamudi (Department: 1611)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

C528S038000, C523S106000

Reexamination Certificate

active

07579021

ABSTRACT:
Matrix controlled diffusion drug delivery systems based on one or more silicon-containing monomers of the general formula:wherein L, X−, n, R1, R2, R3, R4, R5, R6, R7 and V are as set forth herein.

REFERENCES:
patent: 4486577 (1984-12-01), Mueller et al.
patent: 4605712 (1986-08-01), Mueller et al.
patent: 5273530 (1993-12-01), del Cerro et al.
patent: 5409457 (1995-04-01), del Cerro et al.
patent: 2002/0002362 (2002-01-01), Humayun et al.
patent: 2003/0108494 (2003-06-01), Fender et al.
patent: 2004/0043067 (2004-03-01), Salamone et al.
patent: 2004/0253293 (2004-12-01), Shafiee et al.
patent: 2007/0142584 (2007-06-01), Schorzman et al.
patent: 2007/0242215 (2007-10-01), Schorzman et al.
patent: 2008/0152540 (2008-06-01), Schorzman et al.
Kwon, Younggil. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists. Jun. 24, 2001, pp. 207-228.
“Metabolomics,”www.en.wikipedia.org/wiki/Metabolomics, Accessed Apr. 24, 2008.

Affiliated with

Also associated with

Rating

Drug delivery systems based on degradable cationic siloxanyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug delivery systems based on degradable cationic siloxanyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug delivery systems based on degradable cationic siloxanyl... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081448